Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP945444.RAx3sX5YS65Ly5AT-YwAyQBo71nwfahqI2NoLtBZwNxI0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP945444.RAx3sX5YS65Ly5AT-YwAyQBo71nwfahqI2NoLtBZwNxI0130_assertion type Assertion NP945444.RAx3sX5YS65Ly5AT-YwAyQBo71nwfahqI2NoLtBZwNxI0130_head.
- NP945444.RAx3sX5YS65Ly5AT-YwAyQBo71nwfahqI2NoLtBZwNxI0130_assertion description "[Now that rapid genetic testing for BRCA1 and BRCA2 mutations is available at the time of breast cancer diagnosis, BRCA mutation status can be considered when making treatment and prevention decisions for BRCA mutation carriers with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP945444.RAx3sX5YS65Ly5AT-YwAyQBo71nwfahqI2NoLtBZwNxI0130_provenance.
- NP945444.RAx3sX5YS65Ly5AT-YwAyQBo71nwfahqI2NoLtBZwNxI0130_assertion evidence source_evidence_literature NP945444.RAx3sX5YS65Ly5AT-YwAyQBo71nwfahqI2NoLtBZwNxI0130_provenance.
- NP945444.RAx3sX5YS65Ly5AT-YwAyQBo71nwfahqI2NoLtBZwNxI0130_assertion SIO_000772 22157293 NP945444.RAx3sX5YS65Ly5AT-YwAyQBo71nwfahqI2NoLtBZwNxI0130_provenance.
- NP945444.RAx3sX5YS65Ly5AT-YwAyQBo71nwfahqI2NoLtBZwNxI0130_assertion wasDerivedFrom befree-2016 NP945444.RAx3sX5YS65Ly5AT-YwAyQBo71nwfahqI2NoLtBZwNxI0130_provenance.
- NP945444.RAx3sX5YS65Ly5AT-YwAyQBo71nwfahqI2NoLtBZwNxI0130_assertion wasGeneratedBy ECO_0000203 NP945444.RAx3sX5YS65Ly5AT-YwAyQBo71nwfahqI2NoLtBZwNxI0130_provenance.